PDT Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Sell
17,844
-75,961
-81% -$1.33M 0.01% 453
2026
Q1
$1.8M Sell
93,805
-16,580
-15% -$360K 0.11% 259
2025
Q4
$2.43M Sell
110,385
-60,035
-35% -$1.08M 0.16% 217
2025
Q3
$2.07M Hold
170,420
0.13% 245
2025
Q2
$3.18M Buy
+170,420
New +$3.38M 0.18% 198
2023
Q2
Sell
-17,886
Closed -$726K 652
2023
Q1
$726K Sell
17,886
-11,724
-40% -$485K 0.1% 330
2022
Q4
$1.33M Buy
29,610
+15,850
+115% +$718K 0.22% 163
2022
Q3
$658K Buy
+13,760
New +$754K 0.1% 351
2022
Q2
Sell
-26,756
Closed -$3.11M 1157
2022
Q1
$3.11M Sell
26,756
-1,464
-5% -$171K 0.27% 91
2021
Q4
$4.25M Sell
28,220
-22,783
-45% -$3.08M 0.32% 82
2021
Q3
$6.09M Sell
51,003
-8,200
-14% -$903K 0.44% 19
2021
Q2
$5.77M Sell
59,203
-2,679
-4% -$239K 0.38% 36
2021
Q1
$5.46M Sell
61,882
-11,367
-16% -$1.06M 0.39% 26
2020
Q4
$7.01M Buy
73,249
+18,448
+34% +$1.9M 0.47% 26
2020
Q3
$6.22M Sell
54,801
-11,208
-17% -$1.18M 0.41% 89
2020
Q2
$6.53M Buy
+66,009
New +$5.27M 0.44% 86
2015
Q3
Sell
-2,694
Closed -$292K 1563
2015
Q2
$292K Buy
+2,694
New +$335K 0.01% 1140
2014
Q4
Sell
-1,722
Closed -$231K 1073
2014
Q3
$231K Buy
+1,722
New +$241K 0.01% 1150
2014
Q2
Sell
-1,860
Closed -$411K 1635
2014
Q1
$411K Buy
+1,860
New +$474K 0.01% 1034

Other funds holding TNDM

PDT Partners's TNDM Position: Q2 2026 in Review

PDT Partners reduced its Tandem Diabetes Care (TNDM) stake by 81% in Q2 2026, selling an estimated $1.33M and leaving 17,844 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #453.

PDT Partners first reported a position in TNDM in Q1 2014 and has held it in 19 quarters since. The position peaked at $7.01M in Q4 2020. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • PDT Partners held 17,844 shares of Tandem Diabetes Care worth $269K as of Q2 2026.
  • PDT Partners sold 75,961 Tandem Diabetes Care shares in Q2 2026, an estimated $1.33M.
  • Tandem Diabetes Care made up 0.01% of PDT Partners's portfolio in Q2 2026, its #453 holding.
  • PDT Partners first reported a position in Tandem Diabetes Care in Q1 2014 and has held it in 19 quarters since.
  • PDT Partners's Tandem Diabetes Care position peaked at $7.01M in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.